Skip to main content

1 Result(s)

within English Remove this filter Science, multidisciplinary Remove this filter Matthew F. Cusick Remove this filter

and

  1. Article

    Open Access

    Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer

    Immune checkpoint inhibitors (ICI) are important treatment options for metastatic non-small cell lung cancer (mNSCLC). However, not all patients benefit from ICIs and can experience immune-related adverse even...

    Cindy Y. Jiang, Lili Zhao, Michael D. Green, Shashidhar Ravishankar… in Scientific Reports (2024)

    Download PDF (1268 KB) View Article